Standards Related to Essential Health Benefits, Actuarial Equivalence, and Accreditation (77 Fed. Reg. 70,644); Budget Control Act of 2011 (P.L. 112-25); Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); American Taxpayer Relief Act of 2012 (P.L. 112-240); Comprehensive ESRD Care Initiative; CMS-1526-F: Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; H.R. 4302, the Protecting Access to Medicare Act of 2014; Medicare payment and coverage issues.
Standards Related to Essential Health Benefits, Actuarial Equivalence, and Accreditation (77 Fed. Reg. 70,644); Budget Control Act of 2011 (P.L. 112-25); Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); American Taxpayer Relief Act of 2012 (P.L. 112-240); Comprehensive ESRD Care Initiative; CMS-1526-F: Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; H.R. 4302, the Protecting Access to Medicare Act of 2014; payment and coverage issue; ACOs.
Duration: January 1, 2008
to
June 30, 2014
General Issues: Medicare/Medicaid , Health Issues
Spending: about $1,920,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2014
Squire Patton Boggs (formerly Patton Boggs LLP) terminated an engagement in which they represented Kidney Care Council on July 9, 2014.
Original Filing: 300654434.xml
Lobbying Issues
Standards Related to Essential Health Benefits, Actuarial Equivalence, and Accreditation (77 Fed. Reg. 70,644); Budget Control Act of 2011 (P.L. 112-25); Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); American Taxpayer Relief Act of 2012 (P.L. 112-240); Comprehensive ESRD Care Initiative; CMS-1526-F: Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; H.R. 4302, the Protecting Access to Medicare Act of 2014; Medicare payment and coverage issues.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Standards Related to Essential Health Benefits, Actuarial Equivalence, and Accreditation (77 Fed. Reg. 70,644); Budget Control Act of 2011 (P.L. 112-25); Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); American Taxpayer Relief Act of 2012 (P.L. 112-240); Comprehensive ESRD Care Initiative; CMS-1526-F: Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; H.R. 4302, the Protecting Access to Medicare Act of 2014; payment and coverage issue; ACOs.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2014
In Q1, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $60,000. The report was filed on April 19, 2014.
Original Filing: 300642719.xml
Lobbying Issues
Standards Related to Essential Health Benefits, Actuarial Equivalence, and Accreditation (77 Fed. Reg. 70,644); Budget Control Act of 2011 (P.L. 112-25); Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); American Taxpayer Relief Act of 2012 (P.L. 112-240); Comprehensive ESRD Care Initiative; CMS-1526-F: Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; H.R. 4302, the Protecting Access to Medicare Act of 2014
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medicare/Medicaid Health Issues
4th Quarter, 2013
In Q4, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $80,000. The report was filed on Jan. 17, 2014.
Original Filing: 300619813.xml
Lobbying Issues
Patient Protection and Affordable Care Act; Standards Related to Essential Health Benefits, Actuarial Equivalence, and Accreditation (77 Fed. Reg. 70,644); Budget Control Act of 2011 (P.L. 112-25); Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); American Taxpayer Relief Act of 2012 (P.L. 112-240); Comprehensive ESRD Care Initiative; CMS-1526-P: Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program and Durable Medical Equipment,Prosthetics, Orthotics, and Supplies; Proposed Rule; Final Rule
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Patient Protection and Affordable Care Act; Standards Related to Essential Health Benefits, Actuarial Equivalence, and Accreditation (77 Fed. Reg. 70,644); Budget Control Act of 2011 (P.L. 112-25); Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); American Taxpayer Relief Act of 2012 (P.L. 112-240); Comprehensive ESRD Care Initiative; CMS-1526-P: Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule; Final Rule
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2013
In Q3, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $80,000. The report was filed on Oct. 19, 2013.
Original Filing: 300600852.xml
Lobbying Issues
Patient Protection and Affordable Care Act; Standards Related to Essential Health Benefits, Actuarial Equivalence, and Accreditation (77 Fed. Reg. 70,644); Budget Control Act of 2011 (P.L. 112-25); Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); American Taxpayer Relief Act of 2012 (P.L. 112-240); Comprehensive ESRD Care Initiative; CMS-1526-P: Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program and Durable Medical Equipment,Prosthetics, Orthotics, and Supplies; Proposed Rule
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Patient Protection and Affordable Care Act; Standards Related to Essential Health Benefits, Actuarial Equivalence, and Accreditation (77 Fed. Reg. 70,644); Budget Control Act of 2011 (P.L. 112-25); Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); American Taxpayer Relief Act of 2012 (P.L. 112-240); Comprehensive ESRD Care Initiative; CMS-1526-P: Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
2nd Quarter, 2013
In Q2, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $80,000. The report was filed on July 21, 2013.
Original Filing: 300580605.xml
Lobbying Issues
Patient Protection and Affordable Care Act; Standards Related to Essential Health Benefits, Actuarial Equivalence, and Accreditation (77 Fed. Reg. 70,644); Budget Control Act of 2011 (P.L. 112-25); Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); American Taxpayer Relief Act of 2012 (P.L. 112-240); Comprehensive ESRD Care Initiative
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medicare/Medicaid Health Issues
1st Quarter, 2013
In Q1, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $80,000. The report was filed on April 21, 2013.
Original Filing: 300558436.xml
Lobbying Issues
CY 2013 End-Stage Renal Disease Prospective Payment System Final Rule (CMS-1352-F); Patient Protection and Affordable Care Act; Standards Related to Essential Health Benefits, Actuarial Equivalence, and Accreditation (77 Fed. Reg. 70,644); Budget Control Act of 2011 (P.L. 112-25); Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); American Taxpayer Relief Act of 2012 (P.L. 112-240).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medicare/Medicaid Health Issues
4th Quarter, 2012
In Q4, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $80,000. The report was filed on Jan. 20, 2013.
Original Filing: 300536236.xml
Lobbying Issues
CY 2013 End-Stage Renal Disease Prospective Payment System Final Rule (CMS-1352-F); Patient Protection and Affordable Care Act; Standards Related to Essential Health Benefits, Actuarial Equivalence, and Accreditation (77 Fed. Reg. 70,644); Budget Control Act of 2011 (Pub.L. 112-25); Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); American Taxpayer Relief Act of 2012 (P.L. 112-240).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medicare/Medicaid Health Issues
3rd Quarter, 2012
In Q3, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $80,000. The report was filed on Oct. 19, 2012.
Original Filing: 300513796.xml
Lobbying Issues
S.2163, Kidney Disease Equitable Access, Prevention, and Research Act of 2012
H.R.6011, Kidney Disease Equitable Access, Prevention, and Research Act of 2012 and implementation of new health exchange rules; implementation of Medicare Improvement for Patients and Providers Act (MIPPA)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
S.2163, Kidney Disease Equitable Access, Prevention, and Research Act of 2012; H.R.6011, Kidney Disease Equitable Access, Prevention, and Research Act of 2012 and implementation of new health exchange rules; implementation of Medicare Improvement for Patients and Providers Act (MIPPA)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2012
In Q2, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $80,000. The report was filed on July 20, 2012.
Original Filing: 300498412.xml
Lobbying Issues
S.2163 : Kidney Disease Equitable Access, Prevention, and Research Act of 2012
H.R.6011 : Kidney Disease Equitable Access, Prevention, and Research Act of 2012 and implementation of new health exchange rules
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medicare/Medicaid Health Issues
1st Quarter, 2012
In Q1, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $80,000. The report was filed on April 19, 2012.
Original Filing: 300465078.xml
Lobbying Issues
Issues around the implementation of new health care exchange rules
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medicare/Medicaid Health Issues
4th Quarter, 2011
In Q4, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $80,000. The report was filed on Jan. 17, 2012.
Original Filing: 300438254.xml
Lobbying Issues
CMS-1503-P Medicare Programs; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011 Proposed Rule; CMS-3206-P End-Stage Renal Disease Quality Incentive Program Proposed Rule; The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); End-Stage Renal Disease Prospective Payment System Proposed Rule; Budget Control Act (P.L. 112-25.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
CMS-1503-P Medicare Programs; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011 Proposed Rule; CMS-3206-P End-Stage Renal Disease Quality Incentive Program Proposed Rule; The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); End-Stage Renal Disease Prospective Payment System Proposed Rule; Budget Control Act (P.L. 112-25)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
3rd Quarter, 2011
In Q3, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $70,000. The report was filed on Oct. 20, 2011.
Original Filing: 300425601.xml
Lobbying Issues
CMS-1418-F ESRD Prospective Payment System Final Rule; CMS-1503-P Medicare Programs; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011 Proposed Rule; CMS-3206-P End-Stage Renal Disease Quality Incentive Program Proposed Rule; The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); End-Stage Renal Disease Prospective Payment System Proposed Rule; Budget Control Act (P.L. 112-25)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medicare/Medicaid Health Issues
2nd Quarter, 2011
In Q2, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $70,000. The report was filed on July 19, 2011.
Original Filing: 300394761.xml
Lobbying Issues
CMS-1418-F ESRD Prospective Payment System Final Rule; CMS-1503-P Medicare Programs; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011 Proposed Rule; CMS-3206-P End-Stage Renal Disease Quality Incentive Program Proposed Rule; The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); End-Stage Renal Disease Prospective Payment System; Changes to the End-Stage Renal Disease Prospective Payment System Transition Budget-Neutrality Adjustment Interim Final Rule
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
CMS-1418-F ESRD Prospective Payment System Final Rule; CMS-1503-P Medicare Programs; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011 Proposed Rule; CMS-3206-P End-Stage Renal Disease Quality Incentive Program Proposed Rule; The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); End-Stage Renal Disease Prospective Payment System
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2011
In Q1, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $70,000. The report was filed on April 19, 2011.
Original Filing: 300369053.xml
Lobbying Issues
CMS-1418-F ESRD Prospective Payment System Final Rule; CMS-1503-P Medicare Programs; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011 Proposed Rule; CMS-3206-P End-Stage Renal Disease Quality Incentive Program Proposed Rule; The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); End-Stage Renal Disease Prospective Payment System
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medicare/Medicaid Health Issues
4th Quarter, 2010
In Q4, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $70,000. The report was filed on Jan. 19, 2011.
Original Filing: 300344266.xml
Lobbying Issues
CMS-1418-F ESRD Prospective Payment System Final Rule; CMS-1503-P Medicare Programs; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011 Proposed Rule; CMS-3206-P End-Stage Renal Disease Quality Incentive Program Proposed Rule; The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); End-Stage Renal Disease Prospective Payment System; The Physician Payment and Therapy Relief Act of 2010 (P.L. 111-286)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medicare/Medicaid Health Issues
3rd Quarter, 2010
In Q3, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $80,000. The report was filed on Oct. 18, 2010.
Original Filing: 300314913.xml
Lobbying Issues
CMS-1418-F ESRD Prospective Payment System Final Rule; CMS-1503-P Medicare Programs; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011 Proposed Rule; CMS-3206-P End-Stage Renal Disease Quality Incentive Program Proposed Rule; The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); End-Stage Renal Disease Prospective Payment System
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medicare/Medicaid Health Issues
2nd Quarter, 2010
In Q2, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $80,000. The report was filed on July 19, 2010.
Original Filing: 300291426.xml
Lobbying Issues
P.L. 111-148 Patient Protection and Affordable Care Act
P.L. 111-152 Health Care and Education Reconciliation Act of 2010
P.L. 111-5, American Recovery and Reinvestment Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medicare/Medicaid Health Issues
1st Quarter, 2010
In Q1, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $80,000. The report was filed on April 19, 2010.
Original Filing: 300262484.xml
Lobbying Issues
H.R. 3962, the Affordable Health Care for America Act
H.R. 3590, the Patient Protection and Affordable Care Act
H.R. 4872, the Health Care and Education Reconciliation Act of 2010
Implementation of the Medicare Improvements for Patients and Providers Act (Pub. L. No. 110-275)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medicare/Medicaid Health Issues
4th Quarter, 2009
In Q4, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $80,000. The report was filed on Jan. 20, 2010.
Original Filing: 300240479.xml
Lobbying Issues
The American Recovery and Reinvestment Act (ARRA; P.L. 111-5)
H.R.3962, the Affordable Health Care for America Act (House-passed health reform bill)
H.R.3590, the Patient Protection and Affordable Care Act (Senate health reform bill)
S. 1796 America's Healthy Future Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medicare/Medicaid Health Issues
3rd Quarter, 2009
In Q3, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $70,000. The report was filed on Oct. 19, 2009.
Original Filing: 300210054.xml
Lobbying Issues
H.R. 3200: America's Affordable Health Choice Act of 2009;
S. 1679: Affordable Health Choice Act;
America's Healthy Future Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 3200: America's Affordable Health Choice Act of 2009;
S.1679: Affordable Health Choice Act; America's Healthy Future Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2009
In Q2, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $80,000. The report was filed on July 20, 2009.
Original Filing: 300186332.xml
Lobbying Issues
Medicaid Reform; Implementation of Medicare Modernization Act; Implementation of H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 (Public Law No: 110-275); H.R. 3200 America's Affordable Health Choices Act of 2009; Senate Finance Committee health care reform legislation
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medicare/Medicaid Health Issues
1st Quarter, 2009
In Q1, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $70,000. The report was filed on April 17, 2009.
Original Filing: 300153388.xml
Lobbying Issues
Medicaid Reform; Implementation of Medicare Modernization Act; Kidney Care Quality and Education Act (H.R. 1193/S. 691); Health care quality; pay-for-performance; prevention and wellness; The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162); The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S.2499); H.R. 6331 - Medicare Improvements for Patients and Providers Act of 2008; S.3101, Medicare Improvements for Patients and Providers Act of 2008; S.3118, Preserving Access to Medicare Act of 2008
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Implementation of Medicare Modernization Act; Kidney Care Quality and Education Act (H.R. 1193/S. 691);
Health care quality; pay-for-performance; prevention and wellness; The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162); The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S. 2499); H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008; S.3101, Medicare Improvements for Patients and Providers Act of 2008; S.3118, Preserving Access to Medicare Act of 2008
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2008
In Q4, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $70,000. The report was filed on Jan. 19, 2009.
Original Filing: 300126051.xml
Lobbying Issues
Medicaid Reform; Implementation of Medicare Modernization Act; Kidney Care Quality and Education Act (H.R. 1193/S. 691); Health care quality; pay-for-performance; prevention and wellness; The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162); The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S.2499); H.R. 6331 - Medicare Improvements for Patients and Providers Act of 2008; S.3101, Medicare Improvements for Patients and Providers Act of 2008; S.3118, Preserving Access to Medicare Act of 2008
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Implementation of Medicare Modernization Act; Kidney Care Quality and Education Act (H.R. 1193/S. 691);
Health care quality; pay-for-performance; prevention and wellness; The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162); The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S. 2499); H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008; S.3101, Medicare Improvements for Patients and Providers Act of 2008; S.3118, Preserving Access to Medicare Act of 2008
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2008
In Q3, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $70,000. The report was filed on Oct. 18, 2008.
Original Filing: 300100022.xml
Lobbying Issues
Medicaid Reform; Implementation of Medicare Modernization Act; Kidney Care Quality and Education Act (H.R. 1193/S. 691); Health care quality; pay-for-performance; prevention and wellness; The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162); The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S.2499); H.R. 6331 - Medicare Improvements for Patients and Providers Act of 2008; S.3101, Medicare Improvements for Patients and Providers Act of 2008; S.3118, Preserving Access to Medicare Act of 2008
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Implementation of Medicare Modernization Act; Kidney Care Quality and Education Act (H.R. 1193/S. 691);
Health care quality; pay-for-performance; prevention and wellness; The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162); The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S. 2499); H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008; S.3101, Medicare Improvements for Patients and Providers Act of 2008; S.3118, Preserving Access to Medicare Act of 2008
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2008
In Q2, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $70,000. The report was filed on July 19, 2008.
Original Filing: 300075415.xml
Lobbying Issues
Medicaid Reform; Implementation of Medicare Modernization Act; Kidney Care Quality and Education Act (H.R. 1193/S. 691); Health care quality; pay-for-performance; prevention and wellness; The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162); The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S.2499); H.R. 6331 - Medicare Improvements for Patients and Providers Act of 2008; S.3101, Medicare Improvements for Patients and Providers Act of 2008; S.3118, Preserving Access to Medicare Act of 2008
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Implementation of Medicare Modernization Act; Kidney Care Quality and Education Act (H.R. 1193/S. 691);
Health care quality; pay-for-performance; prevention and wellness; The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162); The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S. 2499); H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008; S.3101, Medicare Improvements for Patients and Providers Act of 2008; S.3118, Preserving Access to Medicare Act of 2008
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2008
PATTON BOGGS LLP amended a lobbying report for representation of Kidney Care Council in Q12008 on April 21, 2008.
Original Filing: 300050123.xml
Lobbying Issues
Medicaid Reform; Implementation of Medicare Modernization Act; Kidney Care Quality and Education Act (H.R. 1193/S. 691); Health care quality; pay-for-performance; prevention and wellness; The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162); The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S. 2499)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)
Lobbying Issues
Implementation of Medicare Modernization Act; Kidney Care Quality and Education Act (H.R. 1193/S. 691);
Health care quality; pay-for-performance; prevention and wellness; The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162); The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S. 2499)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)
1st Quarter, 2008
In Q1, PATTON BOGGS LLP lobbied for Kidney Care Council , earning $70,000. The report was filed on April 20, 2008.
Original Filing: 300046685.xml
Lobbying Issues
Medicaid Reform;
Implementation of Medicare Modernization Act;
Kidney Care Quality and Education Act (H.R. 1193/S. 691);
Health care quality; pay-for-performance; prevention and wellness;
The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162);
The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S. 2499)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)
Lobbying Issues
Implementation of Medicare Modernization Act;
Kidney Care Quality and Education Act (H.R. 1193/S. 691);
Health care quality; pay-for-performance; prevention and wellness;
The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162);
The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S. 2499)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate